AI Maverick Intel Inc. (OTCID: AIMV) announced on Oct. 12, 2026, that it has entered into a definitive share purchase agreement to acquire Heal Access Canada Inc., an artificial intelligence healthcare technology company, from its controlling stockholder, HEAL Group Holdings Inc. The transaction includes $5 million in consideration through a secured, two-year promissory note bearing 10% annual interest, plus 20 million exchangeable shares convertible into AIMV common stock. The acquisition remains subject to several closing conditions, including at least $6 million in financing and independent special committee ratification. AIMV expects to use commercially reasonable efforts to complete the required financing by Dec. 31, 2026, with either party permitted to terminate the agreement if the transaction has not closed by Feb. 28, 2027. The company will also assume approximately $6.4 million in existing obligations owed by Heal Access and its subsidiaries to HEAL Group and affiliates.
This acquisition is significant for the healthcare technology sector as Heal Access operates an AI-powered healthcare intelligence platform that integrates patient information and supports clinical workflows. The platform is operational in five countries and serves more than 118,000 patients, demonstrating its real-world impact and scalability. By acquiring Heal Access, AIMV aims to expand its AI healthcare offerings and grow through further acquisitions of AI and technology-enabled healthcare businesses, including opportunities under its right of first refusal agreement with HEAL Group Holdings Inc. The deal could accelerate the adoption of AI in healthcare, improving patient outcomes and operational efficiencies globally.
AIMV clarified that its Sept. 21 announcement incorrectly described the acquisition agreement as definitive, noting that the binding agreement was signed Oct. 12, 2026. Upon conversion of all exchangeable shares, HEAL Group would hold approximately 80.1% of AIMV common stock before accounting for any shares issued in the financing, potentially giving HEAL Group significant control over AIMV. This concentration of ownership might raise governance concerns but also aligns interests between the controlling stockholder and the company's strategic direction. For investors, the news highlights AIMV's commitment to becoming a leader in AI healthcare, but the financing condition introduces execution risk. The latest news and updates relating to AIMV are available in the company's newsroom at http://ibn.fm/AIMV.
TechMediaWire, a specialized communications platform focused on pioneering public and private companies driving the future of technology, is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries, article and editorial syndication to 5,000+ outlets, enhanced press release enhancement to ensure maximum impact, social media distribution via IBN to millions of social media followers, and a full array of tailored corporate communications solutions.
